Ubs Asset Management Americas Inc Charles River Laboratories International, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 220,686 shares of CRL stock, worth $44.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
220,686
Previous 219,944
0.34%
Holding current value
$44.5 Million
Previous $52 Million
15.0%
% of portfolio
0.02%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding CRL
# of Institutions
728Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.22 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.04 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$422 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$378 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$305 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.2B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...